Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
NeLM news service
Clinical review: The management of myocarditis

Reference: Eur Heart J (2011) 32 (21): 2616-2625

Source: European Heart Journal

Date published: 01/11/2011 16:38

Summary
by: Nicola Pocock

This clinical review discusses the management of myocarditis under the following headings:

 

• Aetiology of myocarditis

• Pathogenic mechanisms

• Diagnosis and prognosis

• Treatment (of heart failure; antiviral treatment; treatment of chronic viral heart disease)

• Immunosuppression

• Intravenous immunoglobulin and immunoadsorption

Link (abstract)

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Related evidence
5.3 Antiviral drugs
25/04/2012
NICE issues final guidance recommending boceprevir for the treatment of genotype 1 chronic hepatitis C
25/04/2012
NICE issues final guidance recommending telaprevir for the treatment of genotype 1 chronic hepatitis C
09/03/2012
AWMSG issues Final Appraisal Recommendation on entecavir (Baraclude®) for hepatitis B infection
8.2.4 Other immunomodulating drugs
27/04/2012
Thalidomide for managing cancer cachexia
25/04/2012
NICE issues final guidance recommending fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis
13/03/2012
SMC does not recommend fingolimod (Gilenya®) for multiple sclerosis
14.5 Immunoglobulins
30/03/2011
Intravenous immunoglobulins for epilepsy
28/07/2010
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
11/05/2010
DTB: I.V. immunoglobulin therapy for infectious diseases
Cardiovascular Medicine
23/05/2012
NICE TA 256: Rivaroxaban for the prevention of stroke and systemic
27/04/2012
Preoperative statin therapy for patients undergoing cardiac surgery
15/03/2012
NICE issues guidance on dabigatran etexilate for prevention of stroke and systemic embolism in AF
Infections
12/04/2012
DTB: Routine vaccination against chickenpox?
01/04/2012
Oxygen therapy for pneumonia in adults
28/03/2012
NICE publishes clinical guideline on the prevention and control of healthcare-associated infections in primary and community care
Related news
5.3 Antiviral drugs
22/05/2012
FDA approves updated labelling for raltegravir (Isentress™)
18/05/2012
CADTH Drug Plan Management issues: Boceprevir and telaprevir for chronic hepatitis C infection
15/05/2012
ACH-3102 receives Fast Track Designation in the US for the treatment of chronic Hepatitis C
8.2.4 Other immunomodulating drugs
17/05/2012
Analysis: Risk of natalizumab-associated Progressive Multifocal Leukoencephalopathy
16/05/2012
Updated national IV monograph on Natalizumab
15/05/2012
FDA Drug Safety Communication: Revised recommendations for cardiac monitoring and use of fingolimod (Gilenya®)
14.5 Immunoglobulins
10/05/2012
IV immunoglobulin versus IV methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: RCT
30/04/2012
Conference report: Small phase III study assesses Gammagard liquid (normal immunoglobulin) for multifocal motor neuropathy (MMN)
26/04/2012
Updated guidelines from American Academy of Neurology and American Headache Society on treatments for episodic migraine prevention in adults
Cardiovascular Medicine
24/05/2012
Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk
24/05/2012
RCT: Aspirin for preventing the recurrence of venous thromboembolism – WARFASA trial
24/05/2012
Horizon scanning: FDA advisory panel recommends against approval of rivaroxaban to reduce the risk of secondary cardiovascular events in patients with acute coronary syndrome
Infections
24/05/2012
HPA: Confirmed case of rabies in London
23/05/2012
HPA issues report on healthcare associated infections (HCAIs)
22/05/2012
RCT: Critical pathway to reduce duration of IV antibiotic therapy and in-patient stay in community-acquired pneumonia
Back